Talee Bio Email Format
Biotechnology ResearchPennsylvania, United States11-50 Employees
Talee Bio is a small biotechnology research company based in Philadelphia, Pennsylvania, focused on developing gene therapies for cystic fibrosis and other genetic lung diseases. Its work aims to overcome the barriers that have limited the effectiveness of genetic treatments for CF, including delivery efficiency, durability of expression, vector capacity, immune responses, and safety and manufacturing challenges. The company is pursuing two gene therapy product candidates to treat CF, supported by an approach designed to address these deficiencies. In 2018, Taleebio was recognized with industry awards for its contributions to CF research. Positioned within the biotechnology research sector, Taleebio concentrates on gene therapy approaches for CF and related lung diseases. It operates from Philadelphia, placing it within a regional ecosystem of life sciences and biotech activity.